Trial · NCT07885748
Four Different Guided Bone Regeneration Strategies for Horizontal Ridge Augmentation in the Maxillary Esthetic Zone With Simultaneous Implant Placement: a Randomized Clinical Trial
NCT07885748, Not applicable, Completed, Mansoura University
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Four Different Guided Bone Regeneration Strategies for Horizontal Ridge Augmentation in the Maxillary Esthetic Zone With Simultaneous Implant Placement: a Randomized Clinical Trial. Trials, record NCT07885748. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07885748
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Four Different Guided Bone Regeneration Strategies for Horizontal Ridge Augmentation in the Maxillary Esthetic Zone With Simultaneous Implant Placement: a Randomized Clinical Trial
- NCT number
- NCT07885748
- Status
- Completed
- Phases
- Not applicable
- Enrollment
- 40 participants, actual
- Lead sponsor
- Mansoura University
- Conditions
- Horizontal Alveolar Ridge Augmentation
- Interventions
- Titanium Mesh-Guided Bone Regeneration, Extended Sticky Bone Augmentation, Medpark Bone Graft Augmentation, Ethoss Synthetic Bone Graft Augmentation
- First posted
- 2026-10-21
- Last updated
- 2026-10-21
Source ClinicalTrials.gov
Registered outcomes5
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change in Alveolar Bone Volume From Baseline to 6 Months | Baseline (preoperative) and 6 months postoperatively | Three-dimensional alveolar bone volume will be assessed using cone-beam computed tomography (CBCT) before surgery (T0) and at 6 months postoperatively (T6). Bone volume gain will be calculated as the difference between bone volume at 6 months and baseline (T6 - T0). The outcome will be compared among the four treatment groups. |
| Secondary | Change in Implant Stability Quotient (ISQ) From Implant Placement to 6 Months | immediately after implant placement and at 6 months postoperatively. | Implant stability will be assessed using resonance frequency analysis (RFA) with an Osstell device. Implant Stability Quotient (ISQ) values will be recorded immediately after implant placement and at 6 months postoperatively. Change in stability will be calculated as the 6-month ISQ value minus the initial ISQ value. Higher ISQ values indicate greater implant stability. |
| Secondary | Soft Tissue Healing Assessed by the Landry Healing Index | 2 weeks, 4 weeks, 3 months, and 6 months postoperatively. | Postoperative soft tissue healing will be evaluated using the Landry Healing Index, based on tissue color, bleeding on palpation, presence of granulation tissue, incision margin condition, and degree of epithelialization. Healing will be assessed at 2 weeks, 4 weeks, 3 months, and 6 months following surgery. |
| Secondary | Initial Alveolar Bone Volume Gain | Preoperatively and within 1 week postoperatively | Three-dimensional bone volume will be measured using cone-beam computed tomography (CBCT) preoperatively (T0) and within one week after surgery (T1). Initial bone volume gain will be calculated as T1 minus T0. |
| Secondary | Change in Augmented Bone Volume During Healing | Within 1 week postoperatively and at 6 months. | Bone volume will be assessed using CBCT immediately postoperatively (T1) and at 6 months (T6). The change will be calculated as T6 minus T1, with negative values indicating bone volume loss. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07885748
GET https://conductscience.org/api/trials/v1/NCT07885748/registered